is wegovy or tirzepatide better for weight loss vs Semaglutide Treatment Wegovy® vs. Zepbound®: Kevin Lost

A 2022 randomized controlled trial comparing GLP-1 monotherapy to GLP-1 plus metformin found that combination therapy reduced fasting insulin by 40% versus 25% in the monotherapy group, suggesting enhanced metabolic benefit

Conclusion In conclusion, the association between GLP 1RAs and an increased risk of depression revealed in this study provides crucial evidence for research on the mental safety of this class of drugs and raises new concerns for clinical practice in the context of their increasingly widespread use

/ : / L-

But the new study is significant because of its size and scope

This allows more granular dose control at very low doses

No trial dates have been set at this stage